BG Medicine Inc. (NSDQ:BGMD) inked another deal to develop a version of its galectin-3 test for heart failure, this time with Health Diagnostics Laboratory Inc.
The diagnostic test screens for the presence of a protein called galectin-3, which is both a predictor and the cause of a certain type of heart failure.
